tradingkey.logo

Elevation Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Achievements

ReutersMar 6, 2025 9:42 PM

- Elevation Oncology Inc ELEV.O:

  • ELEVATION ONCOLOGY Q4 OPERATING EXPENSES USD 10.642 MILLION

  • ELEVATION ONCOLOGY Q4 BASIC EPS USD -0.18

  • ELEVATION ONCOLOGY Q4 INCOME FROM OPERATIONS USD -10.642 MILLION

  • ELEVATION ONCOLOGY Q4 PRETAX PROFIT USD -10.427 MILLION

  • ELEVATION ONCOLOGY Q4 NET INCOME USD -10.436 MILLION

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI